๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

28 recruiting trials

for Endometrioid Ovarian Cancer

Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer NCT05945407NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Indication-extended Fertility-sparing Therapy A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003). NCT06843447Phase 1, Phase 239 sites๐Ÿ“ New Haven๐Ÿ“ Louisville๐Ÿ“ Shreveport Merck Sharp & Dohme LLC ยท Tests: Raludotatug Deruxtecan, Carboplatin, Paclitaxel, Bevacizumab, Rescue Medication Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy NCT07504588Phase 213 sites๐Ÿ“ Fayetteville๐Ÿ“ Rogers๐Ÿ“ Springdale National Cancer Institute (NCI) ยท Tests: Anti-VEGF Monoclonal Antibody, Bevacizumab, Biospecimen Collection, Carboplatin, Computed Tomography Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer NCT06580314Phase 3695 sites๐Ÿ“ Birmingham๐Ÿ“ Anchorage๐Ÿ“ Anchorage NRG Oncology ยท Tests: Bevacizumab, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Olaparib Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma NCT05112601Phase 2138 sites๐Ÿ“ Birmingham๐Ÿ“ Athens๐Ÿ“ Augusta National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Computed Tomography, Ipilimumab, Magnetic Resonance Imaging, Nivolumab Study of NTB-928 in R/R OC NCT07690189Phase 14 sites๐Ÿ“ Birmingham๐Ÿ“ Omaha๐Ÿ“ Lake Success TeneoSeven, Inc. ยท Tests: NTB-928 A Study of Radspherinยฎ in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery NCT06504147Phase 210 sites๐Ÿ“ Tampa๐Ÿ“ Leuven๐Ÿ“ Roma Oncoinvent Solutions AS ยท Tests: Radspherin Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer NCT05080556Phase 21 site๐Ÿ“ London University College, London ยท Tests: Carboplatin APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion NCT04919629Phase 21 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: Bevacizumab, Biopsy, Biospecimen Collection, Pegcetacoplan, Pembrolizumab Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer NCT06468215NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Treatment Option 1 is a single-drug regimen, with oral medroxyprogesterone acetate (MPA) 500mg/d or MA 320mg/d. MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) NCT04111978Phase 353 sites๐Ÿ“ Graz๐Ÿ“ Graz๐Ÿ“ Innsbruck Swiss GO Trial Group ยท Tests: Letrozole 2.5mg, Placebo A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05) NCT07743164Phase 34 sites๐Ÿ“ Fountain Valley๐Ÿ“ Orlando๐Ÿ“ Tel Aviv Merck Sharp & Dohme LLC ยท Tests: R-DXd, Bevacizumab, Carboplatin, Paclitaxel, Gemcitabine CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. NCT06690775Phase 266 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Duarte TORL Biotherapeutics, LLC ยท Tests: TORL-1-23, TORL-1-23, TORL-1-23, Pegfilgrastim (drug) OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy NCT06466382NA10 sites๐Ÿ“ Baden๐Ÿ“ Basel๐Ÿ“ Sankt Gallen Swiss GO Trial Group ยท Tests: Treatment recommendation by molecular tumorboard (mTB) based on tumor profiling, Carboplatin / Paclitaxel Chemotherapy Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer NCT07736937Phase 1, Phase 28 sites๐Ÿ“ Los Angeles๐Ÿ“ East Brunswick๐Ÿ“ New York Gilead Sciences ยท Tests: TUB-040 + Carbo + BEV Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer NCT06617923Phase 22 sites๐Ÿ“ Baltimore๐Ÿ“ Philadelphia Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: Senaparib, Temozolomide A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib NCT05512208Phase 24 sites๐Ÿ“ Orlando๐Ÿ“ New Orleans๐Ÿ“ Albuquerque University of Oklahoma ยท Tests: Avutometinib (VS-6766) + defactinib PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer NCT06549855NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Sintilimab or Pembrolizumab and medroxyprogesterone acetate (MPA)/ megestrol acetate (MA) Trial of THEO-260 in Ovarian Cancer Patients NCT06618235Phase 1, Phase 24 sites๐Ÿ“ Madrid๐Ÿ“ Glasgow๐Ÿ“ London Theolytics Limited ยท Tests: THEO-260 Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial NCT04575935Phase 319 sites๐Ÿ“ Miami๐Ÿ“ Weston๐Ÿ“ Boston M.D. Anderson Cancer Center ยท Tests: Chemotherapy, Laparotomy, Minimally Invasive Surgery, Quality-of-Life Assessment, Questionnaire Administration Folate Receptor Alpha Dendritic Cells (FRฮฑDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial NCT06639074Phase 23 sites๐Ÿ“ Scottsdale๐Ÿ“ Jacksonville๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biopsy, Biospecimen Collection, Computed Tomography, Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorโ€ฆ Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients NCT07211659Phase 11 site๐Ÿ“ Houston Theolytics Limited ยท Tests: THEO-260 Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer NCT06856499Phase 12 sites๐Ÿ“ Aurora๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: Cirtuvivint, Olaparib Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer NCT06463028Phase 218 sites๐Ÿ“ La Jolla๐Ÿ“ San Francisco๐Ÿ“ Miami Beach Faeth Therapeutics ยท Tests: Sapanisertib, Serabelisib, Paclitaxel Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer NCT05231122Phase 22 sites๐Ÿ“ Buffalo๐Ÿ“ Houston Roswell Park Cancer Institute ยท Tests: Anti-CD40 Agonist Monoclonal Antibody CDX-1140, Bevacizumab, Pembrolizumab, Quality-of-Life Assessment, Questionnaire Aโ€ฆ Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer NCT05950464Phase 114 sites๐Ÿ“ Augusta๐Ÿ“ Chicago๐Ÿ“ Iowa City National Cancer Institute (NCI) ยท Tests: BET Bromodomain Inhibitor ZEN-3694, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Magnetic Resonance Iโ€ฆ Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) NCT05281471Phase 333 sites๐Ÿ“ Mobile๐Ÿ“ Tucson๐Ÿ“ Duarte Genelux Corporation ยท Tests: olvimulogene nanivacirepvec, Platinum chemotherapy: carboplatin (preferred) or cisplatin, Non-platinum chemotherapy: Phโ€ฆ Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease NCT04291612n/a18 sites๐Ÿ“ Hartford๐Ÿ“ Miami๐Ÿ“ Orlando Memorial Sloan Kettering Cancer Center ยท Tests: Physical exam
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy